Q2 2025 13F Holders as of 6/30/2025
-
Type / Class
-
Equity / COM
-
Number of holders
-
10
-
Total 13F shares, excl. options
-
70.6K
-
Shares change
-
+70.6K
-
Total reported value, excl. options
-
$258K
-
Value change
-
+$258K
-
Number of buys
-
10
-
Price
-
$3.65
Significant Holders of Protagenic Therapeutics, Inc.\new - COM (PTIX) as of Q2 2025
10 filings reported holding PTIX - Protagenic Therapeutics, Inc.\new - COM as of Q2 2025.
Protagenic Therapeutics, Inc.\new - COM (PTIX) has 10 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 70.6K shares
.
Largest 10 shareholders include Virtu Financial LLC (18.8K shares), Alpine Global Management, LLC (16.4K shares), MORGAN STANLEY (15K shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (10.2K shares), UBS Group AG (9.02K shares), Tower Research Capital LLC (TRC) (876 shares), CITIGROUP INC (390 shares), BANK OF AMERICA CORP /DE/ (6 shares), RAYMOND JAMES FINANCIAL INC (1 shares), and HARBOR INVESTMENT ADVISORY, LLC (1 shares).
This table shows the top 10 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.